Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT07284160
Starting soon Not applicable

A Study on the Effectiveness of Rest Shame Interventions Based on Cognitive Behavioural Therapy in Reducing Social Media Addiction

NCT07284160 · tracked via the Priya Life Science China tracker
Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase
Not applicable
Started
2026-01-01
Last updated
2025-12-16

Condition(s) studied

Rest is Shameful

Investigational drug(s) / intervention(s)

Structured intervention based on cognitive behavioural therapy (CBT)

Structured intervention based on cognitive behavioural therapy (CBT): Structured intervention based on cognitive behavioural therapy (CBT)

Study summary

This study will employ a randomised controlled trial design to systematically intervene in university students' rest shaming through a structured intervention programme grounded in cognitive behavioural therapy (CBT), thereby examining its efficacy in reducing social media addiction. Through this research, we aim to evaluate the effectiveness of CBT interventions in alleviating rest shaming and demonstrate that operationalising rest shaming influences social media addiction.

Eligibility

Sex
ALL
Min age
18 Years
Max age
25 Years
Healthy volunteers
Accepted
Inclusion Criteria: * University students aged 18-25 who are capable of understanding and completing research-related tasks, and who have confirmed the presence of rest shaming experiences via the Rest Shaming Scale. Exclusion Criteria: * Individuals with a history of severe mental illness (such as clinically diagnosed depression, anxiety disorders, etc.), cognitive impairment, or an inability to cooperate in completing the research process.

Primary outcome measure(s)

  • rest intolerance scale — From enrollment to the end of treatment at 1 week
  • Social media addiction — From enrollment to the end of treatment at 1 week

Trial sites (1)

FacilityCityRegionStatus
The Fourth Affiliated Hospital of Zhejiang University School of Medicine Yiwu Zhejiang

More The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials in China

Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis Starting soon
A Stuty on the Treatment and Nursing Care of CIPN Patients With Traditional Chinese Medicine Hot Package Recruiting
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer Recruiting
The Study on the Effect of Different Administration Methods of Simethicone in Reducing Bubbles During Bowel Preparation Starting soon
Randomized Controlled Trial of Berberine in Combination With Doxycycline in the Treatment of Chronic Endometritis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07284160 on ClinicalTrials.gov ↗ ← All trials in China